What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 2, 2014, Pages 128-134

  Buteau, Anna ^a   Seideman, Casey A ^a   Svatek, Robert S ^b   Youssef, Ramy F ^a   Chakrabarti, Gaurab ^a   Reed, Gary ^a   Bhat, Deepa ^a   Lotan, Yair ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Compliance; Electronic medical records; Hematuria; Primary care physicians; Referral

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BLADDER DISEASE; BLADDER TUMOR; CAUCASIAN; CHILD; COHORT ANALYSIS; CYSTITIS; CYSTOSCOPY; CYTOLOGY; ELECTRONIC MEDICAL RECORD; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE POLICY; HEMATURIA; HUMAN; HYDRONEPHROSIS; KIDNEY CANCER; KIDNEY CYST; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NEPHROLITHIASIS; OBSERVATIONAL STUDY; OUTPATIENT CARE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHOOL CHILD; SMOKING; URINALYSIS; URINARY TRACT INFECTION; UROLOGIST; VERY ELDERLY; YOUNG ADULT;

COMPLIANCE; ELECTRONIC MEDICAL RECORDS; HEMATURIA; PRIMARY CARE PHYSICIANS; REFERRAL;

ADULT; AFRICAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; CYSTOSCOPY; CYTODIAGNOSIS; DIAGNOSTIC IMAGING; ELECTRONIC HEALTH RECORDS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEMATURIA; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, PRIMARY CARE; REFERRAL AND CONSULTATION; URINALYSIS;

EID: 84892545189     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.07.001     Document Type: Article

References (19)

1. Cohen R.A., Brown R.S. Clinical practice. Microscopic hematuria. N Engl J Med 2003, 348:2330-2338.
2. Grossfeld G.D., Litwin M.S., Wolf J.S., et al. Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy-Part I: Definition, detection, prevalence, and etiology. Urology 2001, 57:599-603.
3. Mariani A.J., Mariani M.C., Macchioni C., et al. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol 1989, 141:350-355.
4. Britton J.P., Dowell A.C., Whelan P., et al. A community study of bladder cancer screening by the detection of occult urinary bleeding. J Urol 1992, 148:788-790.
5. Bruyninckx R., Buntinx F., Aertgeerts B., et al. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract 2003, 53:31-35.
6. Buntinx F., Wauters H. The diagnostic value of macroscopic haematuria in diagnosing urological cancers: A meta-analysis. Fam Pract 1997, 14:63-68.
7. Khadra M.H., Pickard R.S., Charlton M., et al. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000, 163:524-527.
8. Grossfeld G.D., Litwin M.S., Wolf J.S., et al. Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy-Part II: Patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 2001, 57:604-610.
9. Nieder A.M., Lotan Y., Nuss G.R., et al. Are patients with hematuria appropriately referred to urology?. A multi-institutional questionnaire based survey. Urol Oncol 2010, 28(5):500-503.
10. Yafi F.A., Aprikian A.G., Tanguay S., et al. Patients with microscopic and gross hematuria: Practice and referral patterns among primary care physicians in a universal health care system. Can Urol Assoc J 2011, 5:97-101.
11. Johnson E.K., Daignault S., Zhang Y., et al. Patterns of hematuria referral to urologists: Does a gender disparity exist?. Urology 2008, 72:498-502. Discussion:502-3.
12. Elias K., Svatek R.S., Gupta S., et al. High-risk patients with hematuria are not evaluated according to guideline recommendations. Cancer 2010, 116:2954-2959.
13. Jones R., Latinovic R., Charlton J., et al. Alarm symptoms in early diagnosis of cancer in primary care: Cohort study using general practice research database. BMJ 2007, 334:1040.
14. Summerton N., Mann S., Rigby A.S., et al. Patients with new onset haematuria: Assessing the discriminant value of clinical information in relation to urological malignancies. Br J Gen Pract 2002, 52:284-289.
15. Lotan Y., Shariat S.F. Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection. BJU Int 2008, 101:1362-1367.
16. Grossman H.B., Messing E., Soloway M., et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA 2005, 293:810-816.
17. Siegel R., Naishadham D., Jemal A., et al. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
18. Wallace D.M., Raghavan D., Kelly K.A., et al. Neoadjuvant (preemptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol 1991, 67:60816.
19. Lotan Y., Capitanio U., Shariat S.F., et al. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int 2009, 103:1368-1374.